最新文章：芬苯达唑见证——英国建筑师的妻子分享了她令人难以置信的B细胞非霍奇金淋巴瘤成功案例！我直接帮助过7000多名癌症患者，间接帮助过的患者更是数不胜数。 😃这是一个令人振奋的成功故事。“我被诊断出患有高级别B细胞非霍奇金淋巴瘤”“四月份我第一次接受化疗那天，他（我丈夫）给我看了你对坎贝尔医生的采访，谈到了芬苯达唑的成功应用。”“反正也没什么可失去的，我们就从网上订购了一些，四天后我就开始服用了。”这个故事里没有提到伊维菌素，所以这真的很有意思……“我开始每天服用 222 毫克，在阅读了你们播客下面的评论后，很快就将剂量增加到 444 毫克。”“我六月份做了一次PET扫描，我的血液科医生都惊呆了。她以前从未见过这种情况，一次化疗后，我的淋巴瘤就完全消失了。”“我上周的PET扫描结果再次显示，我的淋巴瘤已经消失了。”“这次她问我能不能把我的案子写下来，还说如果她给我开芬苯达唑，她就会被吊销行医执照。”那岂不是很悲惨吗？这是她的肿瘤科医生从业以来从未见过的成功案例，如果这位肿瘤科医生做了这样的事，她就会被吊销执照。这意味着什么？主流肿瘤学对癌症患者的康复毫无兴趣。我拥有全球最大的伊维菌素癌症患者群体，但不仅仅是伊维菌素。还有芬苯达唑、甲苯达唑，而且很快还会增加几种其他用途的抗寄生虫药物。NEW ARTICLE: FENBENDAZOLE Testimonial - Wife of UK Architect shares an incredible B-cell Non-Hodgkin Lymphoma success story!I've helped over 7000 cancer patients directly and countless more "indirectly". 😃Here is one of those heartwarming success stories."I was diagnosed with Lymphoma B-Cell Non-Hodgkin's high grade""the day I had my first chemotherapy in April he (my husband) showed me your interview with Dr.Campbell talking about the success of Fenbendazole""I had nothing to lose, so we ordered some online and four days later I started taking it"Now, there is no Ivermectin in this story, so this one is really interesting..."I started taking 222mg per day and soon increased the dose to 444mg after reading the comments below your podcast. "I had a PET scan in June, and my haematologist was speechless. She had never seen this before, after one chemotherapy session, I had no more Lymphoma""my PET scan last week again showed I had no more Lymphoma""This time she asked if she could write up my case and said if she prescribed Fenbendazole she would be struck off"Isn't that tragic?A success story her Oncologist had NEVER seen in her entire career and if the Oncologist had done this, she would be "struck off"What does that mean? Mainstream Oncology has no interest in cancer patients getting better. I have the world's largest Ivermectin Cancer Clientele, but it's not just Ivermectin. It's also Fenbendazole, Mebendazole, and soon to be a few more repurposed antiparasitic drugs as well.
